Octreotide Long-acting Release Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of long-acting release octreotide that may be used in the treatment of well-differentiated grade 3 neuroendocrine tumors (NETs), NETs of the pancreas, gastrointestinal (GI) tract, lung, and the thymus, pheochromocytoma/paraganglioma, meningiomas, and Merkel cell carcinoma.

**Synonyms:** - Octreotide Acetate LAR Regimen - Octreotide Acetate Long-acting Release Regimen - Octreotide LAR Regimen - Octreotide LAR monotherapy - Sandostatin LAR Depot Regimen